138 related articles for article (PubMed ID: 10232419)
21. Diagnostic Value of Vascular Endothelial Growth Factor, Transforming Growth Factor-β, Interleukin-8, and the Ratio of Lactate Dehydrogenase to Adenosine Deaminase in Pleural Effusion.
Saraya T; Ohkuma K; Watanabe T; Mikura S; Kobayashi F; Aso J; Nunokawa H; Honda K; Ogawa Y; Tamura M; Sada M; Oda M; Inoue M; Yokoyama T; Kurai D; Ishii H; Kimura H; Takizawa H
Lung; 2018 Apr; 196(2):249-254. PubMed ID: 29353318
[TBL] [Abstract][Full Text] [Related]
22. [The diagnostic usefulness of cholinesterase in pleural exudates].
García Pachón E; Padilla Navas I
Rev Clin Esp; 1997 Jun; 197(6):402-5. PubMed ID: 9304130
[TBL] [Abstract][Full Text] [Related]
23. [Values of TNF, IL-8, sICAM-1 and CD11b/CD18 in benign and malignant pleural effusions].
Huang Y; Xie C
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jan; 24(1):35-9. PubMed ID: 11802937
[TBL] [Abstract][Full Text] [Related]
24. Acute phase markers for the differentiation of infectious and malignant pleural effusions.
Kiropoulos TS; Kostikas K; Oikonomidi S; Tsilioni I; Nikoulis D; Germenis A; Gourgoulianis KI
Respir Med; 2007 May; 101(5):910-8. PubMed ID: 17270413
[TBL] [Abstract][Full Text] [Related]
25. Osteopontin is upregulated in malignant and inflammatory pleural effusions.
Moschos C; Porfiridis I; Psallidas I; Kollintza A; Stathopoulos GT; Papiris SA; Roussos C; Kalomenidis I
Respirology; 2009 Jul; 14(5):716-22. PubMed ID: 19476604
[TBL] [Abstract][Full Text] [Related]
26. [Role of C-C chemokines in the determination of pleural effusion etiology].
Trzaska-Sobczak M; Pierzchała W; Brozek G; Farnik M
Pneumonol Alergol Pol; 2008; 76(6):415-20. PubMed ID: 19173189
[TBL] [Abstract][Full Text] [Related]
27. Tumor necrosis factor-alpha (TNF-alpha) in pleural fluids.
Gürsel G; Gökçora N; Elbeg S; Samurkaşoğlu B; Ekim N
Tuber Lung Dis; 1995 Aug; 76(4):370-1. PubMed ID: 7579322
[TBL] [Abstract][Full Text] [Related]
28. Pleural fluid soluble interleukin 2 receptor in rheumatoid arthritis and systemic lupus erythematosus.
Pettersson T; Söderblom T; Nyberg P; Riska H; Linko L; Klockars M
J Rheumatol; 1994 Oct; 21(10):1820-4. PubMed ID: 7837144
[TBL] [Abstract][Full Text] [Related]
29. Pleural fluid mesothelin for the differential diagnosis of exudative pleural effusions.
Alemán C; Manuel Porcel J; Ma Segura R; Alegre J; Esquerda A; Ruiz E; Bielsa S; de Sevilla TF
Med Clin (Barc); 2009 Oct; 133(12):449-53. PubMed ID: 19783262
[TBL] [Abstract][Full Text] [Related]
30. Production and elimination of hyaluronan in rheumatoid arthritis patients: estimation with a loading test.
Torsteinsdottir I; Groth T; Lindqvist U
Semin Arthritis Rheum; 1999 Feb; 28(4):268-79. PubMed ID: 10073501
[TBL] [Abstract][Full Text] [Related]
31. [Contribution of pleural fluid analysis to the diagnosis of pleural effusion].
Ferreiro L; Toubes ME; Valdés L
Med Clin (Barc); 2015 Aug; 145(4):171-7. PubMed ID: 25433793
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of inflammatory cytokines in malignant and benign pleural effusions.
Alexandrakis MG; Coulocheri SA; Bouros D; Mandalaki K; Karkavitsas N; Eliopoulos GD
Oncol Rep; 2000; 7(6):1327-32. PubMed ID: 11032938
[TBL] [Abstract][Full Text] [Related]
33. Tumour necrosis factor-alpha in comparison to adenosine deaminase in tuberculous pleuritis.
Tahhan M; Ugurman F; Gozu A; Akkalyoncu B; Samurkasoglu B
Respiration; 2003; 70(3):270-4. PubMed ID: 12915746
[TBL] [Abstract][Full Text] [Related]
34. [Interleukin-20 and interleukin-22 in pleural effusion].
Cao TZ; Du RH; Lian Z; Jin W; Qiu M
Zhonghua Jie He He Hu Xi Za Zhi; 2016 Aug; 39(8):608-11. PubMed ID: 27523894
[TBL] [Abstract][Full Text] [Related]
35. Expression Profiles of Cytokine mRNAs in the Pleural Fluid Reveal Differences Among Tuberculosis, Malignancies, and Pneumonia-Exudative Pleural Effusions.
Espósito DL; Bollela VR; Feitosa AL; da Fonseca BA
Lung; 2015 Dec; 193(6):1001-7. PubMed ID: 26407584
[TBL] [Abstract][Full Text] [Related]
36. [Potential role of cholesterol in distinguishing malignant from benign pleural effusion].
Plavec G; Tomić I; Nidzović N; Radojcić B; Aćimović S; Bokun R
Vojnosanit Pregl; 2004; 61(6):607-11. PubMed ID: 15717721
[TBL] [Abstract][Full Text] [Related]
37. A longitudinal study of the hyaluronan level in the serum of patients with malignant mesothelioma under treatment. Hyaluronan as an indicator of progressive disease.
Dahl IM; Solheim OP; Erikstein B; Müller E
Cancer; 1989 Jul; 64(1):68-73. PubMed ID: 2731122
[TBL] [Abstract][Full Text] [Related]
38. Vasoactive mediators (VEGF and TNF-alpha) in patients with malignant and tuberculous pleural effusions.
Hamed EA; El-Noweihi AM; Mohamed AZ; Mahmoud A
Respirology; 2004 Mar; 9(1):81-6. PubMed ID: 14982607
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid. A study of 207 patients.
Villena V; López-Encuentra A; Echave-Sustaeta J; Martín-Escribano P; Ortuño-de-Solo B; Estenoz-Alfaro J
Cancer; 1996 Aug; 78(4):736-40. PubMed ID: 8756365
[TBL] [Abstract][Full Text] [Related]
40. Hyaluronan and N-ERC/mesothelin as key biomarkers in a specific two-step model to predict pleural malignant mesothelioma.
Mundt F; Nilsonne G; Arslan S; Csürös K; Hillerdal G; Yildirim H; Metintas M; Dobra K; Hjerpe A
PLoS One; 2013; 8(8):e72030. PubMed ID: 23991032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
